Survival of ovarian cancer patients in Germany in the early 21st century: A period analysis by age, histology, laterality, and stage

European Journal of Cancer Prevention

Volumn 22, Issue 1, 2013, Pages 59-67

  Chen, Tianhui ^a,b   Jansen, Lina ^b   Gondos, Adam ^b   Emrich, Katharina ^c   Holleczek, Bernd ^d   Katalinic, Alexander ^e   Luttmann, Sabine ^f   Meyer, Martin ^g   Brenner, Hermann ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d SAARLAND CANCER REGISTRY   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

^f LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^g Population Based Cancer Registry Bavaria   (Germany)

Author keywords

cancer registries; Germany; ovarian cancer; period analysis; survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; FEMALE; GERMANY; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY CARCINOMA; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RELATIVE SURVIVAL; STATISTICAL MODEL; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; DATABASES, FACTUAL; DEMOGRAPHY; FEMALE; GERMANY; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84871011770     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283552e28     Document Type: Article

References (48)

1. Balvert-Locht HR, Coebergh JW, Hop WC, Brolmann HA, Crommelin M, van Wijck DJ, Verhagen-Teulings MT (1991). Improved prognosis of ovarian cancer in the Netherlands during the period 1975-1985: A registrybased study. Gynecol Oncol 42:3-8
2. Barnholtz-Sloan JS, Schwartz AG, Qureshi F, Jacques S, Malone J, Munkarah AR (2003). Ovarian cancer: Changes in patterns at diagnosis and relative survival over the last three decades. Am J Obstet Gynecol 189:1120-1127
3. Bast RC Jr., Brewer M, Zou C, Hernandez MA, Daley M, Ozols R, et al. (2007). Prevention and early detection of ovarian cancer: Mission impossible? Recent Results Cancer Res 174:91-100
4. Bjorge T, Engeland A, Sundfor K, Trope CG (1998). Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital. Acta Obstet Gynecol Scand 77:777-781
5. Bjorge T, Engeland A, Hansen S, Trope CG (1998). Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993. Int J Cancer 75:663-670
6. Boger-Megiddo I,Weiss NS (2005). Histologic subtypes and laterality of primary epithelial ovarian tumors. Gynecol Oncol 97:80-83
7. Brenner H, Arndt V (2004). Recent increase in cancer survival according to age: Higher survival in all age groups, but widening age gradient. Cancer Causes Control 15:903-910
8. Brenner H, Gefeller O (1996). An alternative approach to monitoring cancer patient survival. Cancer 78:2004-2010
9. Brenner H, Hakulinen T (2002). Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 20:826-832
10. Brenner H, Hakulinen T (2006). Up-to-date and precise estimates of cancer patient survival: Model-based period analysis. Am J Epidemiol 164:689-696
11. Brenner H, Stegmaier C, Ziegler H (1999). Trends in survival of patients with ovarian cancer in Saarland, Germany, 1976-1995. J Cancer Res Clin Oncol 125:109-113
12. Brenner H, Gefeller O, Hakulinen T (2002). A computer program for period analysis of cancer patient survival. Eur J Cancer 38:690-695
13. Brenner H, Soderman B, Hakulinen T (2002). Use of period analysis for providing more up-to-date estimates of long-term survival rates: Empirical evaluation among 370 000 cancer patients in Finland. Int J Epidemiol 31:456-462
14. Brenner H, Gefeller O, Hakulinen T (2004). Period analysis for 'up-to-date' cancer survival data: Theory, empirical evaluation, computational realisation and applications. Eur J Cancer 40:326-335
15. Brenner H, Stegmaier C, Ziegler H (2005). Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium. Ann Oncol 16:981-986
16. Brenner H, Gondos A, Arndt V (2007). Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol 25:3274-3280
17. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al. (2011). Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 305:2295-2303
18. Carney ME, Lancaster JM, Ford C, Tsodikov A,Wiggins CL (2002). A populationbased study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? Gynecol Oncol 84:36-42
19. Chan JK, Kapp DS, Shin JY, Osann K, Leiserowitz GS, Cress RD, O'Malley C (2008). Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer. Gynecol Oncol 108:95-99
20. Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS (2008). Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 109:370-376
21. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. (2011). Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data. Lancet 377: 127-138
22. Corazziari I, Quinn M, Capocaccia R (2004). Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40:2307-2316
23. Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL (2003). Patterns of chemotherapy use for women with ovarian cancer: A population-based study. J Clin Oncol 21:1530-1535
24. Du BA, Rochon J, Lamparter C, Pfisterer J (2005). Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer 15:183-191
25. Ederer F, Heise H (1959). Instructions to IBM 650 programmers in processing survival computations. Bethesda (MD): National Cancer Institute
26. Ederer F, Axtell LM, Cutler SJ (1961). The relative survival rate: A statistical methodology. Natl Cancer Inst Monogr 6:101-121
27. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). GLOBOCAN 2008, Cancer Incidence and MortalityWorldwide. IARC CancerBase No. 10. Lyon France International Agency for Research on Cancer
28. Lyon, France: International Agency for Research on Cancer. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
29. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (2000). International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization
30. Gadducci A, Cosio S, Gargini A, Genazzani AR (2004). Sex-steroid hormones, gonadotropin and ovarian carcinogenesis: A review of epidemiological and experimental data. Gynecol Endocrinol 19:216-228
31. Gatta G, Lasota MB, Verdecchia A (1998). Survival of European women with gynaecological tumours, during the period 1978-1989. EUROCARE Working Group. Eur J Cancer 34:2218-2225
32. Gondos A, Holleczek B, Arndt V, Stegmaier C, Ziegler H, Brenner H (2007). Trends in population-based cancer survival in Germany: To what extent does progress reach older patients? Ann Oncol 18:1253-1259
33. Gondos A, Bray F, Brewster DH, Coebergh JW, Hakulinen T, Janssen-Heijnen ML, Kurtinaitis J, Brenner H (2008). Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries. Eur J Cancer 44:1463-1475
34. Hamidou Z, Causeret S, Dabakuyo TS, Gentil J, Arnould L, Roignot P, et al. (2010). Population-based study of ovarian cancer in Cote d'Or: Prognostic factors and trends in relative survival rates over the last 20 years. BMC Cancer 10:622
35. Hannibal CG, Cortes R, Engholm G, Kjaer SK (2008). Survival of ovarian cancer patients in Denmark: Excess mortality risk analysis of five-year relative survival in the period 1978-2002. Acta Obstet Gynecol Scand 87: 1353-1360
36. Hiripi E, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, et al. (2012). Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol 23:472-479
37. Holleczek B, Brenner H (2012). Reduction of population-based cancer survival estimates by trace back of death certificate notifications: An empirical illustration. Eur J Cancer 48:797-804
38. Kosary CL (1994). FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 10:31-46
39. Kosary CL (2007). Cancer of the ovary. In: Gloeckler RLA, Young JL, Keel GE, Eisner MP, Lin YD, Horner MJ, editors. SEER Survival Monograph Cancer Survival Among Adults- US SEER Program, 1988-2001, Patient and Tumor Characteristics. SEER Program, NIH Pub No. 07-6215. Bethesda, MD: National Cancer Institute. pp. 133-144
40. Lee KR, Tavassoli FA, Prat J, Dietel M, Gersell DJ, Karseladze AI, et al. (2003). Tumors of the ovary and peritoneum. In: Tavassoli FA, Devilee P, editors. Pathology and Genetics: Tumours of the breast and female genital organs. 1st ed. Lyon: IARC Press. pp. 113-216
41. Levi F, Franceschi S, La VC, Ruzicka J, Gloor E, Randimbison L (1993). Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland. Ann Oncol 4:289-294
42. Lukanova A, Kaaks R (2005). Endogenous hormones and ovarian cancer: Epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 14:98-107
43. Mahdi H, Kumar S, Seward S, Semaan A, Batchu R, Lockhart D, et al. (2011). Prognostic impact of laterality in malignant ovarian germ cell tumors. Int J Gynecol Cancer 21:257-262
44. Quaglia A, Tavilla A, Shack L, Brenner H, Janssen-Heijnen M, Allemani C, et al. (2009). The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 45:1006-1016
45. Roychoudhuri R, Putcha V, Moller H (2006). Cancer and laterality: A study of the five major paired organs (UK). Cancer Causes Control 17:655-662
46. Sankaranarayanan R, Ferlay J (2006).Worldwide burden of gynaecological cancer: The size of the problem. Best Pract Res Clin Obstet Gynaecol 20:207-225
47. Tingulstad S, Skjeldestad FE, Hagen B (2003). The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet Gynecol 102:499-505
48. Vernooij F, Heintz P, Witteveen E, van der Graaf Y (2007). The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: A systematic review. Gynecol Oncol 105:801-812